Table 1. The 12 candidate breast-cancer-associated lncRNAs and their primers for qRT-PCR validation experiments.
| Primers | Primer sequence (5′ to 3′) | |
|---|---|---|
| lnc-CEP170–1:2 | Sense | TGCGAGATTGAGATGATGA |
| Antisense | GCTGAGAACTTACCAGAGT | |
| lnc-CHAD-1:1 | Sense | GTGATGGAGCAAGACTGT |
| Antisense | GGCTGAAGTGTTGAAGGA | |
| lnc-GGCT-1:4 | Sense | TGACAAGAGGAGGAAGGAA |
| Antisense | TGCTGAGATTATAGGTGTGAG | |
| lnc-IL5RA-4:1 | Sense | AAGAGGAGCCAGCACTTC |
| Antisense | AGCCACTGTCCTGATGAAT | |
| lnc-PARN-7:2 | Sense | AGGTGCTGGAGTCAAGAA |
| Antisense | GGTGTGGTTGGTAGGAAG | |
| lnc-PPHLN1–1:1 | Sense | CACACCAAGACGGACTATC |
| Antisense | GAATACTGAAGATGCTGACTG | |
| lnc-PSCA-1:1 | Sense | AGACGAGGCTAATCACTGT |
| Antisense | GGCGGTTGTAAGAGGATG | |
| lnc-SCN5A-1:1 | Sense | CCAGGTCAGGTATCATAATAAG |
| Antisense | CAGTTGTCAAGTAAGCAGTT | |
| lnc-SMARCA5–3:1 | Sense | AGTTAGACCATAATGCCTCT |
| Antisense | GTGTCAATGTGTTACCTTCA | |
| lnc-USP8–2:3 | Sense | GGTAGCAGGTAGGTGTGA |
| Antisense | GTGAAGACATTACTATCCTCCT | |
| lnc-PPHLN1–1:2 | Sense | CACACCAAGACGGACTATC |
| Antisense | GAATACTGAAGATGCTGACTG | |
| lnc-WBSCR16–1:1 | Sense | TCAGTACACCATCCATCCA |
| Antisense | AAGAGTTGAGCAGAGTTCC | |
| GAPDH | Sense | TTGGCTACAGCAACAGGGTG |
| Antisense | GGTCTACATGGCAACTGTGAG |